Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content

Affiliations

10 October 2017

-

doi: 10.3389/fimmu.2017.01244


Abstract

[This corrects the article on p. 798 in vol. 8, PMID: 28769923.].

Keywords: CD56; degranulation; immunodeficiency; interferon-γ; natural killer cells; non-homologous end joining; recombinase-activating genes.


Similar articles

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.

Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena M, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD.Front Immunol. 2017 Jul 17;8:798. doi: 10.3389/fimmu.2017.00798. eCollection 2017.PMID: 28769923 Free PMC article.

Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.

Ghosh S, Nandi M, Pal S, Mukhopadhyay D, Chakraborty BC, Khatun M, Bhowmick D, Mondal RK, Das S, Das K, Ghosh R, Banerjee S, Santra A, Chatterjee M, Chowdhury A, Datta S.Clin Microbiol Infect. 2016 Aug;22(8):733.e9-733.e19. doi: 10.1016/j.cmi.2016.05.009. Epub 2016 May 18.PMID: 27208430

Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56dim Natural Killer Cells.

Lajoie L, Congy-Jolivet N, Bolzec A, Thibault G.Front Immunol. 2017 Nov 20;8:1556. doi: 10.3389/fimmu.2017.01556. eCollection 2017.PMID: 29209315 Free PMC article.

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thélu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E.J Hepatol. 2009 Sep;51(3):458-67. doi: 10.1016/j.jhep.2009.05.030. Epub 2009 Jun 25.PMID: 19596474

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.

Melsen JE, Lugthart G, Lankester AC, Schilham MW.Front Immunol. 2016 Jun 30;7:262. doi: 10.3389/fimmu.2016.00262. eCollection 2016.PMID: 27446091 Free PMC article. Review.


Cited by

Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons.

Tajbakhsh A, Jaberi KR, Hayat SMG, Sharifi M, Johnston TP, Guest PC, Jafari M, Sahebkar A.Adv Exp Med Biol. 2021;1327:63-78. doi: 10.1007/978-3-030-71697-4_5.PMID: 34279829

A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.

Strubbe S, De Bruyne M, Pannicke U, Beyls E, Vandekerckhove B, Leclercq G, De Baere E, Bordon V, Vral A, Schwarz K, Haerynck F, Taghon T.Front Immunol. 2021 Jun 17;12:674226. doi: 10.3389/fimmu.2021.674226. eCollection 2021.PMID: 34220820 Free PMC article.

Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.

Cifaldi C, Brigida I, Barzaghi F, Zoccolillo M, Ferradini V, Petricone D, Cicalese MP, Lazarevic D, Cittaro D, Omrani M, Attardi E, Conti F, Scarselli A, Chiriaco M, Di Cesare S, Licciardi F, Davide M, Ferrua F, Canessa C, Pignata C, Giliani S, Ferrari S, Fousteri G, Barera G, Merli P, Palma P, Cesaro S, Gattorno M, Trizzino A, Moschese V, Chini L, Villa A, Azzari C, Finocchi A, Locatelli F, Rossi P, Sangiuolo F, Aiuti A, Cancrini C, Di Matteo G.Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019.PMID: 31031743 Free PMC article.


KMEL References